SK14212002A3 - Spôsob prípravy (+)-cis-sertralínu - Google Patents

Spôsob prípravy (+)-cis-sertralínu Download PDF

Info

Publication number
SK14212002A3
SK14212002A3 SK1421-2002A SK14212002A SK14212002A3 SK 14212002 A3 SK14212002 A3 SK 14212002A3 SK 14212002 A SK14212002 A SK 14212002A SK 14212002 A3 SK14212002 A3 SK 14212002A3
Authority
SK
Slovakia
Prior art keywords
sertraline
cis
palladium
base
hydrochloride
Prior art date
Application number
SK1421-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Mariuara Mendelovich
Tammy Nidam
Gideon Pilarsky
Neomi Gershon
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of SK14212002A3 publication Critical patent/SK14212002A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/44Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
    • C07C209/52Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of imines or imino-ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82Purification; Separation; Stabilisation; Use of additives
    • C07C209/86Separation
    • C07C209/88Separation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
SK1421-2002A 2000-03-14 2001-03-14 Spôsob prípravy (+)-cis-sertralínu SK14212002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18935500P 2000-03-14 2000-03-14
PCT/US2001/008090 WO2001068566A1 (en) 2000-03-14 2001-03-14 Novel process for preparing (+)-cis-sertraline

Publications (1)

Publication Number Publication Date
SK14212002A3 true SK14212002A3 (sk) 2003-07-01

Family

ID=22696967

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1421-2002A SK14212002A3 (sk) 2000-03-14 2001-03-14 Spôsob prípravy (+)-cis-sertralínu

Country Status (15)

Country Link
US (2) US6552227B2 (hu)
EP (1) EP1268369A4 (hu)
JP (1) JP2003527359A (hu)
KR (3) KR20070002101A (hu)
CN (1) CN1232481C (hu)
AU (2) AU2001243634B2 (hu)
CA (1) CA2402656A1 (hu)
CZ (1) CZ20023269A3 (hu)
HR (1) HRP20020773A2 (hu)
HU (1) HUP0300160A3 (hu)
IL (1) IL151691A0 (hu)
PL (1) PL357262A1 (hu)
SK (1) SK14212002A3 (hu)
WO (1) WO2001068566A1 (hu)
ZA (1) ZA200207225B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552227B2 (en) * 2000-03-14 2003-04-22 Teva Pharmaceutical Industries Ltd. Process for preparing (+)-cis-sertraline
EP1401800A1 (en) * 2001-06-15 2004-03-31 Orion Corporation Fermion A novel process for the preparation of (is-cis) -4-(3, 4-dichlorophenyl) -1, 2, 3, 4 - tetrahydro-n-methyl-1-naphthalenamine
US6723878B2 (en) 2001-06-15 2004-04-20 Orion Corporation Fermion Method for preparing sertraline
US6897340B2 (en) * 2002-04-29 2005-05-24 Teva Pharmaceutical Industries Ltd. Processes for preparation of polymorphic form II of sertraline hydrochloride
EP1583734A2 (en) * 2003-04-14 2005-10-12 Teva Pharmaceutical Industries Limited Hydrogenation of imine intermediates of sertraline with catalysts
CA2537804A1 (en) * 2003-09-05 2005-03-17 Teva Pharmaceutical Industries Ltd A recycling process for preparing sertraline
US8868772B2 (en) 2004-04-30 2014-10-21 Echostar Technologies L.L.C. Apparatus, system, and method for adaptive-rate shifting of streaming content
WO2005121074A2 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Processes for the preparation of sertraline hydrochloride
US7345201B2 (en) * 2005-02-23 2008-03-18 Teva Pharmaceutical Industries, Ltd. Processes for preparing sertraline
GB0507090D0 (en) * 2005-04-07 2005-05-11 Sandoz Ag Process for preparing polymorphic form ll of sertraline hydrochloride
WO2007119247A2 (en) * 2006-04-17 2007-10-25 Unichem Laboratories Limited Improved manufacturing procedure for the preparation of polymorphic form ii of cis-(1s)-n-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthleneamine hydrochloride (sertraline hydrochloride)
KR101340270B1 (ko) 2011-11-10 2013-12-10 보령제약 주식회사 (+)-시스-서트랄린의 선택적인 제조방법
CN103524354A (zh) * 2013-10-23 2014-01-22 山东鲁药制药有限公司 一种盐酸舍曲林的制备方法
CN111763150B (zh) * 2019-12-27 2024-03-08 上虞京新药业有限公司 一种手性盐酸舍曲林的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
GB9114947D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
HU222341B1 (hu) * 1996-12-18 2003-06-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás sertralin előállítására és az eljárásban alkalmazott intermedier
IN191358B (hu) * 1998-01-16 2003-11-29 Pfizer Prod Inc
JP2002506844A (ja) * 1998-03-18 2002-03-05 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド シクロヘキシリデンアミンのcis−選択的接触水素化方法
HU226424B1 (en) * 1998-05-05 2008-12-29 Egis Gyogyszergyar Nyrt Process for producing enantiomer mixture for preparation of sertraline
JP2000026378A (ja) * 1998-07-03 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンの製法
WO2000025598A1 (en) 1998-11-03 2000-05-11 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
YU32700A (sh) 1999-06-09 2002-03-18 Pfizer Products Inc. Postupak za dobijanje sertralina iz hiralnog tetralona
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
IN185109B (hu) 1999-09-01 2000-11-18 Torrent Pharmaceuticals Ltd
SK8872002A3 (en) 1999-12-21 2002-12-03 Teva Pharma Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
US6552227B2 (en) * 2000-03-14 2003-04-22 Teva Pharmaceutical Industries Ltd. Process for preparing (+)-cis-sertraline

Also Published As

Publication number Publication date
HRP20020773A2 (en) 2005-02-28
WO2001068566A1 (en) 2001-09-20
EP1268369A4 (en) 2005-09-21
KR20070002102A (ko) 2007-01-04
US20020019570A1 (en) 2002-02-14
HUP0300160A2 (hu) 2003-06-28
PL357262A1 (en) 2004-07-26
KR20070002101A (ko) 2007-01-04
US6552227B2 (en) 2003-04-22
CN1429188A (zh) 2003-07-09
US20030166970A1 (en) 2003-09-04
JP2003527359A (ja) 2003-09-16
KR20020089394A (ko) 2002-11-29
CZ20023269A3 (cs) 2003-09-17
AU4363401A (en) 2001-09-24
EP1268369A1 (en) 2003-01-02
HUP0300160A3 (en) 2005-07-28
AU2001243634B2 (en) 2006-05-25
US6809221B2 (en) 2004-10-26
KR100704590B1 (ko) 2007-04-10
CA2402656A1 (en) 2001-09-20
ZA200207225B (en) 2003-09-09
IL151691A0 (en) 2003-04-10
CN1232481C (zh) 2005-12-21

Similar Documents

Publication Publication Date Title
EP1224160B1 (en) Process for the preparation of the polymorphic form II of sertraline hydrochloride
SK14212002A3 (sk) Spôsob prípravy (+)-cis-sertralínu
US6500987B1 (en) Sertraline hydrochloride polymorphs
AU2001243634A1 (en) Novel process for preparing (+)-cis-sertraline
JP2507069B2 (ja) L―(―)―2―アミノ―3―(3,4―ジヒドロキシフェニル)プロパン酸の合成方法
US7442838B2 (en) Polymorphic forms of sertraline hydrochloride
JP4538842B2 (ja) 新規ナテグリニド結晶
US7173153B2 (en) Sertraline hydrochloride form II and methods for the preparation thereof
EP1404641B1 (fr) Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
JPH10504519A (ja) 5,6−ジヒドロキシー2−アミノー1,2,3,4−テトラヒドロナフタレン誘導体の製法
WO2006108910A1 (en) Detomidine hydrochloride crystallization method
AU2006201492A1 (en) Novel process for preparing (+)-cis-sertraline
JP2002187875A (ja) 光学活性な2−アミノ−5−メトキシテトラリンの製造方法
CA2544684A1 (en) Process for the preparation of polymorphs of selective serotonin reuptake inhibitor
CA2448300A1 (en) Process for preparing sertraline intermediates
WO1999058493A2 (en) Process for the preparation of optically pure phenylalanine

Legal Events

Date Code Title Description
FC9A Refused patent application